z-logo
Premium
Bone morphogenetic protein‐2 in biodegradable gelatin and β‐tricalcium phosphate sponges enhances the in vivo bone‐forming capability of bone marrow mesenchymal stem cells
Author(s) -
Tadokoro Mika,
Matsushima Asako,
Kotobuki Noriko,
Hirose Motohiro,
Kimura Yu,
Tabata Yasuhiko,
Hattori Koji,
Ohgushi Hajime
Publication year - 2012
Publication title -
journal of tissue engineering and regenerative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.835
H-Index - 72
eISSN - 1932-7005
pISSN - 1932-6254
DOI - 10.1002/term.427
Subject(s) - osteocalcin , mesenchymal stem cell , bone morphogenetic protein 2 , alkaline phosphatase , biomedical engineering , chemistry , in vivo , gelatin , bone marrow , bone morphogenetic protein , bone morphogenetic protein 7 , bone healing , microbiology and biotechnology , in vitro , anatomy , pathology , biochemistry , biology , medicine , enzyme , gene
Bone marrow mesenchymal stem cells (MSCs) have been used for bone tissue engineering due to their osteogenic differentiation capability, but their application is controversial. To enhance their capability, we prepared biodegradable gelatin sponges incorporating β‐tricalcium phosphate ceramics (GT sponge), which has been shown to possess excellent controlled drug‐release properties. The GT sponge was used as a carrier for both rat MSCs and bone morphogenetic protein‐2 (BMP‐2) and osteogenic differentiation was assessed by subcutaneous implantation of four different kinds of implants, i.e. GT‐alone, MSC–GT composites, BMP–GT composites and BMP–GT composites supplemented with MSCs (BMP–MSC–GT) in rats. Two weeks after implantation, histological sections showed new bone formation in the peripheral parts of the BMP–GT and in almost the total volume of the BMP–MSC–GT implants. After 4 weeks, histology as well as microCT analyses demonstrated extensive bone formation in BMP–MSC–GT implants. Gene expression and biochemical analyses of both alkaline phosphatase and bone‐specific osteocalcin confirmed the histological findings. These results indicate that the combination of MSCs, GT and BMP synergistically enhances osteogenic capability and provides a rational basis for their clinical application in bone reconstruction. Copyright © 2011 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here